ACADIA Pharmaceuticals Inc.
MX ˙ BMV ˙ US0042251084
SecurityMX:ACAD / ACADIA Pharmaceuticals Inc.
InstitutionProfund Advisors Llc
Latest Disclosed Ownership84,525 shares
Latest Disclosed Value $ 1,881,527
Profund Advisors Llc reports 9.67% increase in ownership of ACAD / ACADIA Pharmaceuticals Inc.

On April 24, 2026 - Profund Advisors Llc filed a 13F-HR form disclosing ownership of 84,525 shares of ACADIA Pharmaceuticals Inc. (MX:ACAD) valued at $1,881,527 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 6, 2026 disclosing 77,073 shares of ACADIA Pharmaceuticals Inc.. This represents a change in shares of 9.67% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-24 2026-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 84,525 7,452 9.67 1,882 -8.60 0.0691
2026-02-06 2025-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 77,073 31,160 67.87 2,059 110.21 0.0626
2025-11-06 2025-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 45,913 14,961 48.34 980 46.78 0.0318
2025-08-07 2025-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 30,952 -14,308 -31.61 668 -11.19 0.0240
2025-05-08 2025-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 45,260 14,993 49.54 752 35.32 0.0327
2025-02-14 2024-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 30,267 -26,285 -46.48 555 -36.13 0.0203
2024-11-14 2024-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 56,552 -3 -0.01 870 -5.44 0.0329
2024-08-13 2024-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 56,555 -5,375 -8.68 919 -19.74 0.0341
2024-05-08 2024-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 61,930 -8,539 -12.12 1,145 -48.10 0.0446
2024-02-14 2023-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 70,469 12,647 21.87 2,206 83.07 0.0948
2023-11-13 2023-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 57,822 -4,259 -6.86 1,205 -18.91 0.0666
2023-08-10 2023-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 62,081 -660 -1.05 1,487 25.93 0.0798
2023-05-12 2023-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 62,741 62,741 1,181 0.0730
2022-11-04 2022-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 0 -16,026 -100.00 0 -100.00
2022-08-01 2022-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 16,026 -2,133 -11.75 226 -48.64 0.0144
2022-05-10 2022-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 18,159 -2,030 -10.05 440 -6.58 0.0185
2022-02-08 2021-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 20,189 -2,327 -10.33 471 25.94 0.0154
2021-11-12 2021-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 22,516 -955 -4.07 374 -34.50 0.0126
2021-08-12 2021-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 23,471 2,890 14.04 571 7.53 0.0192
2021-05-14 2021-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 20,581 -3,066 -12.97 531 -57.99 0.0204
2021-02-09 2020-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 23,647 2,250 10.52 1,264 43.15 0.0552
2020-11-13 2020-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 21,397 -3,817 -15.14 883 -27.74 0.0454
2020-08-03 2020-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 25,214 2,317 10.12 1,222 26.37 0.0680
2020-05-15 2020-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 22,897 -9,446 -29.21 967 -30.13 0.0726
2020-02-18 2019-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 32,343 5,597 20.93 1,384 43.72 0.0603
2019-11-12 2019-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 26,746 -3,081 -10.33 963 20.83 0.0487
2019-08-13 2019-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 29,827 -3,175 -9.62 797 -10.05 0.0378
2019-05-15 2019-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 33,002 76 0.23 886 66.54 0.0426
2019-02-14 2018-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 32,926 -3,383 -9.32 532 -29.44 0.0329
2018-11-13 2018-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 36,309 2,729 8.13 754 46.98 0.0286
2018-08-13 2018-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 33,580 1,043 3.21 513 -29.82 0.0205
2018-05-14 2018-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 32,537 -3,441 -9.56 731 -32.50 0.0291
2018-02-14 2017-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 35,978 -4,077 -10.18 1,083 -28.23 0.0417
2017-11-13 2017-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 40,055 3,781 10.42 1,509 49.11 0.0628
2017-08-11 2017-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 36,274 -2,215 -5.75 1,012 -23.51 0.0459
2017-04-25 2017-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 38,489 -3,199 -7.67 1,323 10.07 0.0591
2017-02-13 2016-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 41,688 -6,166 -12.89 1,202 -21.02 0.0553
2016-11-10 2016-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 47,854 -327 -0.68 1,522 -2.69 0.0724
2016-08-12 2016-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 48,181 -3,523 -6.81 1,564 8.16 0.0761
2016-05-06 2016-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 51,704 -6,464 -11.11 1,446 -30.28 0.0749
2016-02-05 2015-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 58,168 -331 -0.57 2,074 7.18 0.0984
2015-11-06 2015-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 58,499 58,499 1,935 0.1103
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.